PPTA Testifies at USITC COVID-19 Related Goods Hearing
On Wednesday, September 23, at the invitation of the U.S. International Trade Commission (USITC), PPTA President & CEO, Amy Efantis testified before the USITC at a virtual hearing on COVID-19 Related Goods: The U.S. Industry, Market, Trade, and Supply Chain Challenges. The main messages that PPTA conveyed were that the plasma protein therapeutics industry is built on a complex, global supply chain that must be preserved to ensure access for the patients that depend on it. Additionally, it is of vital importance that the Administration continue to support policies that encourage plasma donation.
This hearing was in support of a report requested by the U.S. House of Representatives’ Committee on Ways and Means and the U.S. Senate Committee on Finance to provide detailed information on COVID-related industry sectors and particular products. The text of the PPTA testimony can be found here.
- Created on .